VNDA PEER ANALYSIS

Vanda Pharmaceuticals Inc — metric-by-metric comparison with peers and the industry median

VNDAVanda Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

VNDAIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	VNDA	MSB	TLX	RTALB	Ind. Median
P/E	—	—	—	4.89	17.81
P/B	1.32	—	6.56	0.61●	3.49
EV/EBITDA	—	—	123.31	74.61●	14.92
P/S	1.70●	31.91	3.34	6.67	10.89

Financial Health
Metric	VNDA	MSB	TLX	RTALB	Ind. Median
Current Ratio	2.16●	—	1.43	1.21	5.90
Debt/Equity	4.7%	—	112.3%	1.2%●	10.9%
NetDebt/EBITDA	1.39	—	13.13	0.90●	1.15

Profitability
Metric	VNDA	MSB	TLX	RTALB	Ind. Median
Net Margin	-110.0%	-115.3%	-0.9%	136.3%●	-125.7%
ROE	-60.5%	-11.3%	-1.8%	15.1%●	-47.5%
ROA	-45.0%	-8.6%	-0.7%	13.1%●	-35.8%
EBITDA Margin	-62.6%	-76.6%	3.0%	9.0%●	-105.8%

Growth + Dividend
Metric	VNDA	MSB	TLX	RTALB	Ind. Median
Rev. Growth	8.2%	410.4%●	56.3%	24.0%	5.1%
NI Growth	—	—	—	134.0%	12.1%
Div. Yield	—	0.0%●	—	0.0%●	0.2%
Payout	—	0.0%	—	0.0%	0.0%

Valuation
Metric	VNDA	FHTX	FENC	CABA	EDIT	LCTX	Ind. Median
P/E	—	—	—	—	—	—	17.81
P/B	1.32	-4.60●	10.09	3.26	81.05	6.45	3.49
EV/EBITDA	—	—	—	—	—	—	14.92
P/S	1.70●	12.44	7.45	—	9.23	23.50	10.89

Financial Health
Metric	VNDA	FHTX	FENC	CABA	EDIT	LCTX	Ind. Median
Current Ratio	2.16	2.92	6.98●	2.95	3.22	6.89	5.90
Debt/Equity	4.7%	-55.0%●	—	25.6%	1,632.8%	4.4%	10.9%
NetDebt/EBITDA	1.39	1.97	—	0.53	0.52●	1.18	1.15

Profitability
Metric	VNDA	FHTX	FENC	CABA	EDIT	LCTX	Ind. Median
Net Margin	-110.0%	-266.9%	-16.4%●	—	-281.6%	-434.4%	-125.7%
ROE	-60.5%	—	-52.7%●	-156.0%	-326.1%	-96.6%	-47.5%
ROA	-45.0%	-31.3%	-14.2%●	-112.0%	-52.8%	-58.0%	-35.8%
EBITDA Margin	-62.6%	-257.0%	-13.1%●	—	-258.7%	-291.9%	-105.8%

Growth + Dividend
Metric	VNDA	FHTX	FENC	CABA	EDIT	LCTX	Ind. Median
Rev. Growth	8.2%	20.1%	65.0%●	-100.0%	8.0%	54.6%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on VNDA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.